Zeo Scientifix Inc Receivables Turnover Ratio (BPSR), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Zeo Scientifix Inc   (BPSR)
 

Zeo Scientifix Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Zeo Scientifix Inc 's ability to collect accounts receivable sequentially worsen to 79.85, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Zeo Scientifix Inc 's Accounts Receivable average collection period in the Apr 30 2026 quarter, has increased to 5 days, from 1 days, in the Jan 31 2026 quarter.

If we take a look into Healthcare sector 22 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Apr 30 2026 from 62 to 208.

What is Receivable Turnover Ratio?
What is Zeo Scientifix Inc Selling?


What is Receivable Turnover Ratio?





BPSR Receivables Turnover Ratio (Apr 30 2026)
II. Quarter
(Jan 31 2026)
I. Quarter
(Oct 31 2025)
IV. Quarter
(Jul 31 2025)
III. Quarter
(Apr 30 2025)
II. Quarter
Y / Y Receivable Change 2200 % 442.86 % -82.23 % -96.77 % -83.33 %
Y / Y Revenue Change 124.63 % 32.66 % 32.96 % 19.71 % 1.59 %
Receivable Turnover Ratio (TTM) 79.85 258.37 378.11 88.28 74.07
BPSR's Total Ranking # 208 # 62 # 49 # 62 # 70
Accounts Receivable average collection period days 5 1 1 4 5
Seq. Receivable Change 626.32 % 8.57 % 3400 % -91.67 % 71.43 %
Seq. Revenue Change 78.49 % -12.58 % 26.65 % 13.66 % 5.41 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 5
Healthcare Sector # 23
Overall Market # 208

Receivable Turnover Ratio Statistics
High Average Low
573.27 80.29 4.74
(Oct 31 2016)   (Jul 31 2017)






Financial Statements
Zeo Scientifix Inc 's Accounts Receivable $ 0 Millions Visit BPSR's Balance sheet
Zeo Scientifix Inc 's Sales TTM $ 7 Millions Visit BPSR's Income Statement
Sources of BPSR's Revenues Visit BPSR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BPSR's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BPSR's Growth Rates BPSR's Roa BPSR's Inventory Turnover Ratio BPSR's Dividend Comparisons
BPSR's Profitability Ratios BPSR's Roi BPSR's Asset Turnover Ratio BPSR's Dividend Growth
BPSR's Valuation Ratios BPSR's Roe BPSR's Financial Strength Ratios BPSR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Apr 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Apr 30 2026 Receivable at quarter ending Apr 30 2026
Lifevantage Corp  67.74 $ 193.618  Millions$ 2.858  Millions
Sangamo Therapeutics Inc   64.62 $ 34.557  Millions$ 0.535  Millions
Hims and Hers Health Inc   63.35 $ 2,369.476  Millions$ 37.405  Millions
Humacyte Inc   58.59 $ 34.376  Millions$ 0.587  Millions
Aim Immunotech Inc   53.71 $ 0.094  Millions$ 0.002  Millions
Agenus Inc  51.40 $ 123.866  Millions$ 2.410  Millions
Brookdale Senior Living Inc   49.21 $ 3,145.058  Millions$ 63.914  Millions
Precision Biosciences Inc  45.03 $ 45.073  Millions$ 1.001  Millions
Fortrea Holdings Inc   44.31 $ 2,708.600  Millions$ 61.125  Millions
National Vision Holdings Inc   41.80 $ 2,021.044  Millions$ 48.351  Millions
Metagenomi Therapeutics Inc   41.78 $ 22.331  Millions$ 0.535  Millions
Nature s Sunshine Products inc   39.69 $ 489.104  Millions$ 12.324  Millions
Vireo Growth Inc.  39.45 $ 350.469  Millions$ 8.884  Millions
Innovative Eyewear Inc   33.59 $ 2.981  Millions$ 0.089  Millions
Electrocore Inc   32.90 $ 34.458  Millions$ 1.047  Millions
U S Physical Therapy Inc  30.94 $ 795.488  Millions$ 25.708  Millions
Innovage Holding Corp   30.49 $ 949.172  Millions$ 31.126  Millions
Silence Therapeutics Plc  29.70 $ 0.839  Millions$ 0.028  Millions
Invo Fertility Inc   29.40 $ 7.219  Millions$ 0.246  Millions
Marpai Inc  29.03 $ 17.125  Millions$ 0.590  Millions
Lineage Cell Therapeutics Inc   28.42 $ 14.779  Millions$ 0.520  Millions
Jaguar Health Inc   28.17 $ 29.569  Millions$ 1.050  Millions
Meiragtx Holdings Plc  28.01 $ 79.758  Millions$ 2.848  Millions
Cv Sciences Inc   27.37 $ 11.925  Millions$ 0.436  Millions
Wave Life Sciences Ltd   27.36 $ 88.173  Millions$ 3.223  Millions
Safe Pro Group Inc   27.29 $ 1.642  Millions$ 0.060  Millions
Atara Biotherapeutics Inc   27.03 $ 23.540  Millions$ 0.871  Millions
Biorestorative Therapies Inc   25.41 $ 0.363  Millions$ 0.014  Millions
Kiniksa Pharmaceuticals International Plc  24.63 $ 754.045  Millions$ 30.618  Millions
Polomar Health Services, Inc.  24.47 $ 1.649  Millions$ 0.067  Millions

Date modified: 2026-09-26T07:28:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.